Skin Care Pharma has developed the generic version of Advantan.
The 5 formulations of the original product generate a combined turnover of over 80 million.

Solution: DCP procedures in 7 countries finish.
Milk: Half time reached in DCP procedure with 6 countries. Approval is expected in 05.2020

DCP procedure started in 7 EU countries. Approval is expected in 12.2020


The registration trial was completed positively in 01.2020 and preparations for submission are ongoing. Approval is expected in 01-02.2021

Fatty ointment:

Confirmation of the German authority BfArM concerning the formulation is available


 The finest clothing made is a person’s own skin but, of course, society demands something more than this.
— Mark Twain
Do NOT follow this link or you will be banned from the site!